Draft:Zur Rose Group

EQS-News: Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group

Monday, August 17, 2020 - 5:02pm

The Zur Rose Group has successfully completed the acquisition of the e-commerce and diabetes activities of Apotal.

Key Points: 
  • The Zur Rose Group has successfully completed the acquisition of the e-commerce and diabetes activities of Apotal.
  • The Swiss Zur Rose Group is Europe's largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland.
  • With its business model, the Zur Rose Group offers high-quality, safe and cost-effective pharmaceutical care.
  • The shares of Zur Rose Group AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker ROSE).

EQS-News: Zur Rose Group successfully concluded acquisition of TeleClinic

Friday, July 31, 2020 - 6:01pm

The Zur Rose Group has successfully completed the acquisition of TeleClinic GmbH, Munich.

Key Points: 
  • The Zur Rose Group has successfully completed the acquisition of TeleClinic GmbH, Munich.
  • For the Zur Rose Group, the acquisition is a strategically important building block, adding complementary telemedicine services to the Zur Rose Healthcare Ecosystem.
  • The Swiss Zur Rose Group is Europe's largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland.
  • The shares of Zur Rose Group AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker ROSE).